40.40 - 41.05
29.80 - 47.18
2.12M / 3.68M (Avg.)
18.02 | 2.27
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
87.35%
Revenue growth above 1.5x VTLE's 8.30%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
167.60%
Gross profit growth above 1.5x VTLE's 21.36%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
626.67%
EBIT growth above 1.5x VTLE's 29.01%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
626.67%
Operating income growth above 1.5x VTLE's 29.01%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
269.37%
Net income growth under 50% of VTLE's 2441.66%. Michael Burry would suspect the firm is falling well behind a key competitor.
267.80%
EPS growth under 50% of VTLE's 2700.00%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
268.94%
Diluted EPS growth under 50% of VTLE's 2600.00%. Michael Burry would worry about an eroding competitive position or excessive dilution.
0.77%
Share count expansion well above VTLE's 0.13%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
-0.01%
Reduced diluted shares while VTLE is at 0.41%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-27.09%
Dividend reduction while VTLE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
63.91%
OCF growth at 75-90% of VTLE's 82.73%. Bill Ackman would demand better working capital management or cost discipline.
77.45%
FCF growth above 1.5x VTLE's 41.41%. David Dodd would verify if the firm’s strategic investments yield superior returns.
48.21%
10Y revenue/share CAGR above 1.5x VTLE's 32.10%. David Dodd would confirm if management’s strategic vision consistently outperforms the competitor.
-72.38%
Negative 5Y CAGR while VTLE stands at 32.10%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
35.33%
3Y revenue/share CAGR 1.25-1.5x VTLE's 32.10%. Bruce Berkowitz might see better product or regional expansions than the competitor.
-20.66%
Negative 10Y OCF/share CAGR while VTLE stands at 31.40%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-71.73%
Negative 5Y OCF/share CAGR while VTLE is at 31.40%. Joel Greenblatt would question the firm’s operational model or cost structure.
-37.84%
Negative 3Y OCF/share CAGR while VTLE stands at 31.40%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
64.92%
Positive 10Y CAGR while VTLE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-39.07%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
244.85%
Positive short-term CAGR while VTLE is negative. John Neff would see a clear advantage in near-term profit trajectory.
-17.51%
Negative equity/share CAGR over 10 years while VTLE stands at 87.77%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
-74.01%
Negative 5Y equity/share growth while VTLE is at 87.77%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
-68.30%
Negative 3Y equity/share growth while VTLE is at 87.77%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
305.40%
Dividend/share CAGR of 305.40% while VTLE is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-63.33%
Negative 5Y dividend/share CAGR while VTLE stands at 0.00%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-26.38%
Negative near-term dividend growth while VTLE invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-13.44%
Firm’s AR is declining while VTLE shows 1.02%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
-19.51%
Inventory is declining while VTLE stands at 216.85%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
0.54%
Asset growth well under 50% of VTLE's 6.85%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
12.03%
BV/share growth above 1.5x VTLE's 4.68%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-0.22%
We’re deleveraging while VTLE stands at 7.02%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
-6.00%
We cut SG&A while VTLE invests at 4.39%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.